Michael S. Cuffe, EVP and Chief Clinical Officer at HCA Healthcare, Inc. (HCA), sold 5,550 shares at $498.09 ($747K) on 2026-02-03, disclosed to the SEC on 2026-02-05.
Seasonal sale ($747k) by EVP and Chief Clinical Officer — this insider has traded HCA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,050 | $0 | 0.0% |
| 2 | $498.09 | 1,500 | $747K | 100.0% |
| Total | $134.62 avg | 5,550 | $747K | 100% |
| Filing → |
| HCA | SELL | 2024-05-13 | $4.0M | — | Filing → |
| HCA | SELL | 2024-05-08 | $494K | — | Filing → |
| HCA | SELL | 2024-02-02 | $2.0M | — | Filing → |